Discussions at the American Academy of Dermatology annual meeting emphasized that chronic spontaneous urticaria (CSU) is more complex than previously thought. Evolving research is challenging the long-held view that the condition is primarily driven by immunoglobulin E (IgE), opening the door to new treatment approaches.
Instead of focusing solely on IgE, investigators are examining additional pathways involved in CSU. These new insights are expected to support more targeted therapies, moving beyond the traditional model of the disease and toward individualized care for patients.